Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals
- PMID: 28636637
- PMCID: PMC5479576
- DOI: 10.1371/journal.pone.0179834
Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals
Abstract
To evaluate if plasma kisspeptin concentrations are associated with insulin secretion, as suggested by recent in vitro studies, independently of confounders. 261 nondiabetic subjects were stratified into tertiles according to kisspeptin values. Insulin secretion was assessed using indexes derived from oral glucose tolerance test (OGTT). After adjusting for age, gender, and BMI, subjects in the highest (tertile 3) kisspeptin group exhibited significantly lower values of insulinogenic index, corrected insulin response (CIR30), and Stumvoll indexes for first-phase and second-phase insulin release as compared with low (tertile 1) or intermediate (tertile 2) kisspeptin groups. Univariate correlations between kisspeptin concentration and metabolic variables showed that kisspeptin concentration was significantly and positively correlated with age, blood pressure, and 2-h post-load glucose, and inversely correlated with BMI, and waist circumference. There was an inverse relationship between kisspeptin levels and OGTT-derived indexes of glucose-stimulated insulin secretion. A multivariable regression analysis in a model including all the variables significantly correlated with kisspeptin concentration showed thar age (β = -0.338, P<0.0001), BMI (β = 0.272, P<0.0001), 2-h post-load glucose (β = -0.229, P<0.0001), and kisspeptin (β = -0.105, P = 0.03) remained associated with insulinogenic index. These factors explained 34.6% of the variance of the insulinogenic index. In conclusion, kisspeptin concentrations are associated with insulin secretion independently of important determinants of glucose homeostasis such as gender, age, adiposity, 2-h post-load glucose, and insulin sensitivity.
Conflict of interest statement
Similar articles
-
Plasma complement C3 levels are associated with insulin secretion independently of adiposity measures in non-diabetic individuals.Nutr Metab Cardiovasc Dis. 2015 May;25(5):510-7. doi: 10.1016/j.numecd.2015.02.007. Epub 2015 Feb 25. Nutr Metab Cardiovasc Dis. 2015. PMID: 25813686
-
Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects.Nutr Metab Cardiovasc Dis. 2009 Dec;19(10):713-9. doi: 10.1016/j.numecd.2008.12.011. Epub 2009 Apr 5. Nutr Metab Cardiovasc Dis. 2009. PMID: 19346116
-
High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes.Diabetologia. 2005 Apr;48(4):732-40. doi: 10.1007/s00125-005-1701-y. Epub 2005 Mar 12. Diabetologia. 2005. PMID: 15765221
-
Kisspeptin and Glucose Homeostasis.Semin Reprod Med. 2019 May;37(3):141-146. doi: 10.1055/s-0039-3400242. Epub 2019 Dec 23. Semin Reprod Med. 2019. PMID: 31869842 Review.
-
Kisspeptin as a potential biomarker throughout pregnancy.Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:261-266. doi: 10.1016/j.ejogrb.2019.07.016. Epub 2019 Jul 16. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 31344665 Review.
Cited by
-
Kisspeptin-13 Improves Spatial Memory Consolidation and Retrieval against Amyloid-β Pathology.Iran J Pharm Res. 2019 Fall;18(Suppl1):169-181. doi: 10.22037/ijpr.2019.112199.13599. Iran J Pharm Res. 2019. PMID: 32802097 Free PMC article.
-
Kisspeptin upregulates β-cell serotonin production during pregnancy.J Endocrinol. 2023 Dec 18;260(2):e230218. doi: 10.1530/JOE-23-0218. Print 2024 Feb 1. J Endocrinol. 2023. PMID: 37997938 Free PMC article.
-
Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects.Exp Biol Med (Maywood). 2021 Jan;246(2):163-176. doi: 10.1177/1535370220962708. Epub 2020 Oct 12. Exp Biol Med (Maywood). 2021. PMID: 33045853 Free PMC article. Clinical Trial.
-
Kisspeptin and Metabolism: The Brain and Beyond.Front Endocrinol (Lausanne). 2018 Apr 16;9:145. doi: 10.3389/fendo.2018.00145. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29713310 Free PMC article. Review.
-
Metabolic actions of kisspeptin signaling: Effects on body weight, energy expenditure, and feeding.Pharmacol Ther. 2022 Mar;231:107974. doi: 10.1016/j.pharmthera.2021.107974. Epub 2021 Sep 14. Pharmacol Ther. 2022. PMID: 34530008 Free PMC article. Review.
References
-
- Lee JH and Welch DR. Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. Int. J. Cancer. 1997;71:1035–1044. - PubMed
-
- Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 2001;411:613–617. doi: 10.1038/35079135 - DOI - PubMed
-
- Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein coupled receptor GPR54. J. Biol. Chem. 2001;276:34631–34636 doi: 10.1074/jbc.M104847200 - DOI - PubMed
-
- Gottsch ML, Clifton DK, Steiner RA. From KISS1 to kisspeptins: An historical perspective and suggested nomenclature. Peptides.2008;30:4–9. doi: 10.1016/j.peptides.2008.06.016 - DOI - PMC - PubMed
-
- Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J. Biol. Chem. 2001;276: 28969–28975. doi: 10.1074/jbc.M102743200 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical